Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Aug;3(4):621–625. doi: 10.1111/j.1365-2125.1976.tb04885.x

Controlled trial of frusemide as an antiepileptic drug in focal epilepsy

S Ahmad, Lesley Clarke, A J Hewett, A Richens
PMCID: PMC1428896  PMID: 22216504

Abstract

1 The antiepileptic activity of oral frusemide (120 mg daily) was compared with that of an identical placebo in a double-blind crossover trial in fourteen patients with severe focal epilepsy who were receiving long-term therapy with established antiepileptic drugs.

2 A statistically significant reduction in the frequency of focal fits was seen with the active drug.

3 Marked drowsiness occurred in three patients during frusemide therapy, causing their withdrawal from the trial.

4 A slight, but significant, rise in serum phenobarbitone concentrations was observed during frusemide therapy, but no change was seen in serum primidone or phenytoin concentrations.

5 Frusemide significantly lowered plasma sodium and potassium concentrations, and increased plasma bicarbonate.

Full text

PDF
621

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askari A., Rao S. N. Drugs affecting sodium transport in human erythrocyte ghosts. J Pharmacol Exp Ther. 1970 Apr;172(2):211–223. [PubMed] [Google Scholar]
  2. Buhrley L. E., Reed D. J. The effect of furosemide on sodium-22 uptake into cerebrospinal fluid and brain. Exp Brain Res. 1972 Apr 27;14(5):503–510. doi: 10.1007/BF00236592. [DOI] [PubMed] [Google Scholar]
  3. Clasen R. A., Pandolfi S., Casey D., Jr Furosemide and pentobarbital in cryogenic cerebral injury and edema. Neurology. 1974 Jul;24(7):642–648. doi: 10.1212/wnl.24.7.642. [DOI] [PubMed] [Google Scholar]
  4. Doose H. Therapie langdauernder cerebraler Anfälle und des Status epilepticus im Kindesalter. Monatsschr Kinderheilkd. 1967 Oct;115(10):537–538. [PubMed] [Google Scholar]
  5. Dreyer R. Die Behandlung des Status epilepticus. Med Welt. 1969 May 24;21:1211–passim. [PubMed] [Google Scholar]
  6. KRAMER G. ZUR MEDIKAMENTOESEN REGULIERUNG DES WASSERHAUSHALTES BEIM HIRNOEDEM. Med Welt. 1964 Oct 17;42:2238–2244. [PubMed] [Google Scholar]
  7. Kielczewska-Mrozikiewicz Badania doświadczalne nad wpływem Lasixu na wystepowanie drgawek kardiazolowych. Przegl Lek. 1968;24(9):716–718. [PubMed] [Google Scholar]
  8. Sullivan L. P., Tucker J. M., Scherbenske M. J. Effect of furosemide on sodium transport and metabolism in toad bladder. Am J Physiol. 1971 May;220(5):1316–1324. doi: 10.1152/ajplegacy.1971.220.5.1316. [DOI] [PubMed] [Google Scholar]
  9. Toseland P. A., Grove J., Berry D. J. An isothermal GLC determination of the plasma levels of carbamazepine, diphenylhydantoin, phenobarbitone and primidone. Clin Chim Acta. 1972 May;38(2):321–328. doi: 10.1016/0009-8981(72)90122-2. [DOI] [PubMed] [Google Scholar]
  10. Wiley J. S., Cooper R. A. A furosemide-sensitive cotransport of sodium plus potassium in the human red cell. J Clin Invest. 1974 Mar;53(3):745–755. doi: 10.1172/JCI107613. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES